Publisher
Springer International Publishing
Reference23 articles.
1. Dunlop DA, Papapoulos SE, Lodge RW, Fulton AJ, Kendall BE, O’Riordan JL. Parathyroid venous sampling: anatomic considerations and results in 95 patients with primary hyperparathyroidism. Br J Radiol. 1980;53:183–91. doi: 10.1259/0007-1285-53-627-183 . [Clinical Study, Level 3B].
2. Reitz RE, Pollard JJ, Wang CA, Fleischli DJ, Cope O, Murray TM, et al. Localization of parathyroid adenomas by selective venous catherization and radioimmunoassay. N Engl J Med. 1969;281:348–51. Population/Observational; Level 3; Grade A-B.
3. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts Jr JT, Segre GV. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33(8):1364–7. Population/Observational; Level 3; Grade A-B.
4. Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilesikian JP. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab. 2003;88:4725–30. [Clinical Study – EBM 3B].
5. Sugg SL, Fraker DL, Alexander R, Doppman JL, Miller DL, Chang R, Skarulis MC, Marx SJ, Spiegel AM, Norton JA. Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperparathyroidism. Surgery. 1993;114:1004–9. [Clinical Study 3B].